Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore

Research To Practice | Oncology Videos · Feb 9, 2026 · 54m

Featuring an interview with Dr Kathleen N Moore, including the following topics:

Overview of the mechanism of action and pharmacology of antibody-drug conjugates (ADCs) (0:00)

Comparing toxicities of conventional chemotherapy and ADCs (6:26)

Potential of ADCs as maintenance therapy for ovarian cancer (11:35)

Treatment based on platinum sensitivity and homologous recombination-deficiency status (15:10)

Case: A woman in her mid 70s presenting with Stage IV ovarian cancer receives raludotatug deruxtecan (18:46)

Case: A woman in her mid 60s with relapsed/refractory ovarian cancer receives…